RIBOMIC
R&D medicine based on their own platform for developing medicine
RIBOMIC
Industry:
Biotechnology Health Care Medical
Founded:
2003-08-01
Address:
Minato, Chiba, Japan
Country:
Japan
Website Url:
http://www.ribomic.com
Total Employee:
1+
Status:
Active
Technology used in webpage:
Apple Whitelist Microsoft Ajax Content Delivery Network Equinix
Similar Organizations
PuraPharm
PuraPharm is a pharmaceutical company that develops medicine.
Stock Details
Official Site Inspections
http://www.ribomic.com
- Host name: host11.drm.co.jp
- IP address: 153.122.22.186
- Location: Japan
- Latitude: 35.69
- Longitude: 139.69
- Timezone: Asia/Tokyo
More informations about "RIBOMIC"
会社概要｜株式会社リボミック
株式会社リボミックの会社概要／役員紹介／沿革／アクセスなどをご紹介いたします。See details»
Company｜RIBOMIC Inc. - 株式会社リボミック
May 2, 2018 · Ophthalmic Therapeutics Development Specialist. Founded at Itabashi-ku, Tokyo. The head office was moved to 3-15 Shirokanedai, Minato-ku, Tokyo. Entered into a …See details»
RIBOMIC Inc.
Read More. Video. InvestorsSee details»
Ribomic Inc. (TYO: 4591) Company Profile & Overview - Stock …
2 days ago · Ribomic Inc. was incorporated in 2003 and is headquartered in Tokyo, Japan. Company profile for Ribomic Inc. (TYO: 4591) with a description, list of executives, contact …See details»
Ribomic - Crunchbase Company Profile & Funding
Ribomic is a research and development company that provides new drugs for diseases. RIBOMIC develops molecularly targeted pharmaceutical drugs using RNA aptamers.See details»
Ribomic, Inc. - VentureRadar
The Ribomic Aptamer Refined Therapeutics (RiboART) system is the core of RIBOMIC drug discovery technology. Overall, it consists of technology, expertise, and experience in aptamer …See details»
RIBOMIC INC. Company Profile | MINATO-KU, TOKYO, Japan
RIBOMIC INC. Company Profile | MINATO-KU, TOKYO, Japan | Competitors, Financials & Contacts - Dun & BradstreetSee details»
Ribomic Company Profile 2024: Stock Performance
Ribomic Inc is a biopharmaceutical venture company based in Tokyo. The company is developing molecular targeted pharmaceutical drugs using RNA aptamers with its unique and advanced platform technologies, the RiboART …See details»
Notice Regarding Joint Research Agreement with RIBOMIC Inc.
RIBOMIC Inc. (Minato-ku, Tokyo, President: Yoshikazu Nakamura) and Ajinomoto Co., Inc. (Chuo-ku, Tokyo, President: Taro Fujie) are pleased to announce that they have entered into a …See details»
株式会社リボミック
株式会社リボミックはアプタマーで治療法のない病気の薬をつくります。 創薬技術「RiboARTシステム」を活用して、疾患や標的タンパク質に限定されない様々な新薬を創製する創薬事業を展開しています。See details»
Ribomic Inc. (4591.T) Stock Price, News, Quote & History - Yahoo …
Find the latest Ribomic Inc. (4591.T) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
Ribomic, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
ABOUT RIBOMIC RIBOMIC is a clinical stage bio-pharmaceutical company specializing in the discovery and development of aptamer therapeutics, which is one type of nucleic acid …See details»
RIBOMIC - Products, Competitors, Financials, Employees, …
RIBOMIC (TYO:4591) operates as a bio-venture company centered on drug discovery. It engages in the field of aptamer therapeutics. It develops molecular-targeted pharmaceutical drugs using …See details»
Ribomic Inc, 4591:TYO profile - FT.com - Financial Times
6 days ago · Ribomic Inc (4591:TYO) company profile with history, revenue, mergers & acquisitions, peer analysis, institutional shareholders and more.See details»
CEO Message｜RIBOMIC Inc. - 株式会社リボミック
As a corporation involved in the research and development of pharmaceutical drugs for human life and health, we conduct research based on cutting-edge science and technology with an …See details»
RIBOMIC Announces Preliminary Topline Data From Phase 2 Trials …
Dec 28, 2021 · TOKYO-- ( BUSINESS WIRE )--RIBOMIC, Inc., a clinical stage pharmaceutical company specializing in aptamer therapeutics (TOKYO:4591), today announced the topline …See details»
RIBOMIC Announces Completion of IND Submission - Business Wire
Apr 19, 2022 · RIBOMIC is a clinical stage bio-pharmaceutical company specializing in the discovery and development of aptamer therapeutics, which is one type of nucleic acid …See details»
RIBOMIC Announces Positive Interim Results from Phase IIa Trial …
TOKYO, November 05, 2024--(BUSINESS WIRE)--RIBOMIC, Inc. (TOKYO:4591), a clinical-stage pharmaceutical company specializing in aptamer therapeutics, has been conducting a Phase …See details»
事業内容 - 株式会社リボミック
株式会社リボミックはアプタマーで治療法のない病気の薬をつくります。 創薬技術「RiboARTシステム」を活用して、疾患や標的タンパク質に限定されない様々な新薬を創製する創薬事業 …See details»
Graph neural network for cerebral blood flow prediction with …
14 hours ago · Various simulation models have been developed to predict cerebral blood flow (CBF) in the brain. For example, Moore et al. [] developed a 1D flow model for the circle of …See details»